Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Clinical Isolates of Streptococcus pneumoniae with Different Susceptibilities to Ceftriaxone and Cefotaxime

James A. Karlowsky, Mark E. Jones, Deborah C. Draghi, Daniel F. Sahm
James A. Karlowsky
Focus Technologies, Herndon, Virginia 20171
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jkarlowsky@focustechnologies.com
Mark E. Jones
Focus Technologies, Herndon, Virginia 20171
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah C. Draghi
Focus Technologies, Herndon, Virginia 20171
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel F. Sahm
Focus Technologies, Herndon, Virginia 20171
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.47.10.3155-3160.2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Scatterplot of ceftriaxone and cefotaxime MICs determined by broth microdilution for 1,000 isolates of S. pneumoniae. The solid line is the linear regression line (r = 0.977). The area between the two diagonal dotted lines contains isolates with ceftriaxone MICs and cefotaxime MICs within ±1 doubling dilution of each other. The vertical dotted lines divide the isolates into ceftriaxone susceptible (MIC, ≤1 μg/ml), intermediate (MIC, 2 μg/ml), and resistant (MIC, ≥4 μg/ml) groups; the horizontal dotted lines divide the isolates into cefotaxime susceptible (MIC, ≤1 μg/ml), intermediate (MIC, 2 μg/ml), and resistant (MIC, ≥4 μg/ml) groups.

Tables

  • Figures
  • TABLE 1.

    In vitro susceptibilities of 1,000 isolates of S. pneumoniae to ceftriaxone and cefotaxime tested by broth microdilution and E-test

    Test method and antimicrobial agentIsolate phenotypeaMIC (μg/ml)MIC interpretationb
    RangeModeMIC50MIC90% Susceptible% Intermediate% Resistant
    Broth microdilution
        CeftriaxoneAll isolates≤0.004-80.0150.015198.60.60.8
    Penicillin susceptible≤0.004-0.50.0150.0150.0310000
    Penicillin intermediate0.015-10.50.250.510000
    Penicillin resistant0.12-811192.63.24.3
        CefotaximeAll isolates≤0.004-80.0150.015196.61.81.6
    Penicillin susceptible≤0.004-10.0150.0150.0310000
    Penicillin intermediate0.015-10.12, 0.50.25110000
    Penicillin resistant0.25-811281.99.68.5
    E-test
        CeftriaxoneAll isolates0.004-40.0120.0160.598.30.80.9
    Penicillin susceptible0.004-0.750.0120.0120.03210000
    Penicillin intermediate0.012-10.380.190.510000
    Penicillin resistant0.25-40.750.5191.04.34.8
        CefotaximeAll isolates0.004-80.0160.023195.82.61.6
    Penicillin susceptible0.004-10.0160.0160.04710000
    Penicillin intermediate0.016-10.380.190.7510000
    Penicillin resistant0.38-8111.577.713.88.5
    • ↵ a Of the 1,000 isolates tested, 666 were penicillin susceptible, 146 were penicillin intermediate, and 188 were penicillin resistant.

    • ↵ b MICs interpreted using NCCLS 2003 guidelines (19).

  • TABLE 2.

    Genetic relatedness of 26 clinical isolates of S. pneumoniae with different MIC interpretative phenotypes for ceftriaxone and cefotaxime

    TABLE 2.
PreviousNext
Back to top
Download PDF
Citation Tools
Clinical Isolates of Streptococcus pneumoniae with Different Susceptibilities to Ceftriaxone and Cefotaxime
James A. Karlowsky, Mark E. Jones, Deborah C. Draghi, Daniel F. Sahm
Antimicrobial Agents and Chemotherapy Sep 2003, 47 (10) 3155-3160; DOI: 10.1128/AAC.47.10.3155-3160.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Isolates of Streptococcus pneumoniae with Different Susceptibilities to Ceftriaxone and Cefotaxime
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical Isolates of Streptococcus pneumoniae with Different Susceptibilities to Ceftriaxone and Cefotaxime
James A. Karlowsky, Mark E. Jones, Deborah C. Draghi, Daniel F. Sahm
Antimicrobial Agents and Chemotherapy Sep 2003, 47 (10) 3155-3160; DOI: 10.1128/AAC.47.10.3155-3160.2003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
cefotaxime
ceftriaxone
Streptococcus pneumoniae

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596